Article
Association between interleukin-22 genetic polymorphisms and bladder cancer risk.
Clinics (Sao Paulo, Brazil) - 1 Oct 2015
Zhao Tao, Wu XiaoHou, Liu JiaJi
Abstract excerpt
OBJECTIVE: The cytokine interleukin-22 (IL-22), which is produced by T cells and natural killer cells, is associated with tumorigenesis and tumor progression in cancers. However, the role of IL-22 in bladder cancer has not been investigated. MATERIALS AND METHODS: A prospective hospital-based case-control study comprising 210 patients with pathologically proven bladder cancer and 210 age- and gender-matched...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
